Profit Or Loss [Abstract]

Xbrane Biopharma - Filing #702448

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Other income
15 557 SEK
17 557 SEK
Administrative expenses
31 395 SEK
26 505 SEK
Profit (loss) from operating activities
180 583 SEK
217 436 SEK
Profit (loss) before tax
183 226 SEK
218 126 SEK
Profit (loss) from continuing operations
183 226 SEK
218 126 SEK
Profit (loss) from discontinued operations
5 150 SEK
7 900 SEK
Profit (loss)
188 376 SEK
188 376 SEK
226 026 SEK
226 026 SEK
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent
188 376 SEK
226 026 SEK
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share from continuing operations
777.00
1,248.00
Basic earnings (loss) per share
798.00
1,248.00
Diluted earnings per share [abstract]
Diluted earnings (loss) per share from continuing operations
7 ,77
1,248.00
Diluted earnings (loss) per share
798.00
1,248.00

Talk to a Data Expert

Have a question? We'll get back to you promptly.